Results 301 to 310 of about 774,384 (405)

ABS0261 ALTERED TRYPTOPHAN PATHWAY METABOLISM AND ASSOCIATION WITH RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE IN ANTI-MDA5 POSITIVE DERMATOMYOSITIS

Huiqing Liu, Ye Guo, Xinyu Dai, J Zhang, Qingmei Xie   +4 more
openalex   +1 more source

Nanoparticles as a Potential Cause of Pleural and Interstitial Lung Disease

, 2010
James C. Bonner
openalex   +2 more sources

Interstitial lung disease in children [PDF]

Indian Pediatrics, 2013
openaire   +2 more sources

Rodent monocyte‐derived macrophages do not express CD163: Comparative analysis using macrophages from living boreoeutherians

Developmental Dynamics, EarlyView.
Abstract Background CD163 is a scavenger receptor predominantly expressed on the surfaces of macrophages in various mammalian species and is a marker of anti‐inflammatory (M2‐like) macrophages. High density of CD163‐positive tumor‐associated macrophages (TAMs) is associated with worse prognosis in various patient tumors.
Yoichi Saito, Yukio Fujiwara, Yasuka L. Yamaguchi, Satomi S. Tanaka, Kyoko Miura, Yoshiyuki Hizukuri, Kyoko Yamashiro, Yasuhiro Hayashi, Yuta Nakashima, Yoshihiro Komohara   +9 more
wiley   +1 more source

How to handle IPF – the new Portuguese consensus document

Revista Portuguesa de Pneumologia (English Edition), 2016
Ulrich Costabel, Francesco Bonella
doaj   +1 more source

Refractory Spontaneous Pneumothorax in Interstitial Lung Disease Under Pirfenidone Treatment. [PDF]

Respirol Case Rep
Jeong J, Kang MK.
europepmc   +1 more source

Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 799-808, April 2025.
Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu, Zhenbang Gu, Wengen Zhu, Shenghui Feng   +3 more
wiley   +1 more source

Pulmonary Hypertension Associated with Interstitial Lung Disease: Screening and Epidemiology. [PDF]

ATS Sch
Rutland C, Hall CS, Kolaitis NA, Kulkarni T, Lancaster LH, Das M, Shen E, Davis BNJ, Nathan SD.   +8 more
europepmc   +1 more source

Biomarkers of lung congestion and injury in acute heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 781-789, April 2025.
Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi, Gabriele Novello, Francesca Bursi, Anna Caretti, Noemi Furlotti, Ross Arena, Paola Argiento, Julio Núñez, Antoni Bayes‐Genis, Marco Metra   +9 more
wiley   +1 more source

Immuno-OncologyThe adverse event of interstitial lung disease in patients treated with antibody-drug conjugates. [PDF]

Oncologist
Fang N, Wang X, Xu Z, Zhan H, Wang Y, Zhao B, Huang H, Lin M.   +7 more
europepmc   +1 more source